Publication
Post-COVID-19 neurocandidiasis
| dc.contributor.author | Miranda, MA | |
| dc.contributor.author | Sousa, SC | |
| dc.contributor.author | Montes, VL | |
| dc.date.accessioned | 2024-12-01T16:00:19Z | |
| dc.date.available | 2024-12-01T16:00:19Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Associated with a significant morbidity and mortality, neurocandidiasis affects severely immunocompromised patients, especially if recently treated with antibiotics or corticosteroids. We present the case of a 70-year-old man admitted to an intensive care unit due to a Sars-Cov-2 pneumonia, with fever, coma, and multifocal neurological deficits reported 13 days after extubation. After isolation of Candida albicans in both urine and blood cultures and a brain MRI with multiple gadolinium-enhanced ring lesions, a diagnosis of neurocandidiasis was assumed and aggressive antifungal therapy started. During treatment, the patient developed a hospital-acquired pneumonia with fatal outcome. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Neurol Sci . 2021 Nov;42(11):4419-4420. | pt_PT |
| dc.identifier.doi | 10.1007/s10072-021-05515-5 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.26/52931 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.subject | COVID-19 | pt_PT |
| dc.subject | Candidiase | pt_PT |
| dc.subject | Candidiasis | pt_PT |
| dc.title | Post-COVID-19 neurocandidiasis | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 4420 | pt_PT |
| oaire.citation.issue | 11 | pt_PT |
| oaire.citation.startPage | 4419 | pt_PT |
| oaire.citation.title | Neurological Sciences | pt_PT |
| oaire.citation.volume | 42 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |